Morgan Stanley analyst Drew Ranieri initiates coverage on Integra Lifesciences (NASDAQ:IART) with a Equal-Weight rating and announces Price Target of $59.
$100 Invested In This Stock 20 Years Ago Would Be Worth $3,100 Today
Amphenol (NYSE:APH) has outperformed the market over the past 20 years by 11.11% on an annualized basis producing an average annual return of 18.95%. Currently, Amphenol has a market capitalization of $47.27 billion.
